Niva Bupa Health
Niva Bupa Health Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years. Niva Bupa expects a continued strong growth trajectory with retail health growing around 17%-19% CAGR over the next 5 years.
From Niva Bupa Health's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years.
- Projected Gross Written Premium (GWP) could reach around INR 15,000 - 16,000 crores, up from INR 9,433 crores in FY '26.
- Growth drivers include:
- Multichannel distribution expansion, including 58,000 new agents added recently.
- Diversifying product portfolio to cover nearly all income segments except the poorest.
- Expansion in Tier 3 and below cities via the Bharat strategy (virtual agency and bank distribution).
- Increased penetration in digital channels both proprietary and third-party.
- Industry-wise, retail health insurance is expected to grow at about 17%-19% CAGR over 5 years.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Niva Bupa Health said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No specific mention of current or future capex or capital investment plans in the provided transcript.
- Capital raise noted as impacting AUM growth, but no detailed explanation or strategic investment plans given.
- Management emphasizes investment in technology, analytics, and Gen AI as key levers for cost optimization and operational efficiency.
- Focus on expanding distribution channels, including virtual agency and bank distribution, to drive growth.
2 more points management made on capital expenditure plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Niva Bupa Health said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Niva Bupa Health — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹345 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Niva Bupa Health's management said in earlier quarters
Others in Insurance this season
- New India Assurance Company Ltd (Q4 FY26)
Domestic gross direct premium grew by 10.9% in FY26, with a market share increase from 12.56% to 12.74%. Key concall takeaways from New India Assurance Company…
- Star Health & Allied Insurance Company Ltd (Q4 FY26)
Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. Key concall takeaways from Star Health &…
- Go Digit General Insurance Ltd (Q4 FY26)
For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…
- Medi Assist Ser. (Q4 FY26)
Core group business organic growth currently tracking at 8%-10% (same-store growth). Key concall takeaways from Medi Assist Ser.'s Q4 FY26 earnings call — and…
Frequently Asked Questions
What were Niva Bupa Health Q4 FY26 results?
Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years. Niva Bupa expects a continued strong growth trajectory with retail health growing around 17%-19% CAGR over the next 5 years.
What is Niva Bupa Health share price analysis?
Niva Bupa Health currently shows a neutral. The stock trades at a P/E of 84.5 with a market cap of ₹14,718 Cr. Investors should review the full earnings analysis for detailed insights.
Is Niva Bupa Health planning capital expenditure?
No specific mention of current or future capex or capital investment plans in the provided transcript.
Keep Niva Bupa Health on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.